Cargando…

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients

OBJECTIVE: To investigate the impact of anxiety symptoms on depression outcomes in Asian patients with major depressive disorder (MDD) (n=714). METHODS: The 17-item Hamilton Depression Scale (HAMD-17), overall severity, somatic symptoms, and quality of life (QOL) (EuroQOL Questionnaire-5 Dimensions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novick, Diego, Montgomery, William, Aguado, Jaume, Peng, Xiaomei, Haro, Josep Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833363/ https://www.ncbi.nlm.nih.gov/pubmed/27114710 http://dx.doi.org/10.2147/NDT.S90134

Ejemplares similares

Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?
por: Hong, Jihyung, et al.
Publicado: (2015)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study
por: Novick, Diego, et al.
Publicado: (2015)

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
por: Novick, Diego, et al.
Publicado: (2013)

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
por: Novick, Diego, et al.
Publicado: (2017)

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
por: Novick, Diego, et al.
Publicado: (2017)

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting
por: Hong, Jihyung, et al.
Publicado: (2015)

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study
por: Novick, Diego, et al.
Publicado: (2015)

Empirically driven definitions of “good,” “moderate,” and “poor” levels of functioning in the treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2012)

Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia
por: Hong, Jihyung, et al.
Publicado: (2014)

Sex differences in the course of schizophrenia across diverse regions of the world
por: Novick, Diego, et al.
Publicado: (2016)

Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East
por: Hong, Jihyung, et al.
Publicado: (2017)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick, Diego, et al.
Publicado: (2016)

Risk factors for suicide behaviors in the observational schizophrenia outpatient health outcomes (SOHO) study
por: Brugnoli, Roberto, et al.
Publicado: (2012)

Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia
por: Mauriño, Jorge, et al.
Publicado: (2011)

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia
por: Hong, Jihyung, et al.
Publicado: (2013)

Schizophrenia Outpatient Health Outcomes study: twelve-month findings
por: Novick, Diego, et al.
Publicado: (2012)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
por: Huang, Jia, et al.
Publicado: (2018)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
por: Hong, Jihyung, et al.
Publicado: (2012)

Systematic review of depressive, anxiety and post-traumatic stress symptoms among Asian American breast cancer survivors
por: Tsai, William, et al.
Publicado: (2020)

The Association of Social Support and Loneliness with Symptoms of Depression, Anxiety, and Posttraumatic Stress during the COVID-19 Pandemic: A Meta-Analysis
por: Gabarrell-Pascuet, Aina, et al.
Publicado: (2023)

The role of social support, detachment, and depressive and anxiety symptoms in suicidal thoughts and behaviours during the Covid-19 lockdown: Potential pathways
por: Gabarrell-Pascuet, Aina, et al.
Publicado: (2021)

The Impact of the COVID-19 Pandemic on the Lifestyles and Levels of Anxiety and Depression of Patients with Schizophrenia: A Retrospective Observational Study
por: Biviá-Roig, Gemma, et al.
Publicado: (2022)

Psychometric properties of the IDS-SR(30 )for the assessment of depressive symptoms in spanish population
por: Gili, Margalida, et al.
Publicado: (2011)

Distractibility, anxiety, irritability, and agitation symptoms are associated with the severity of depressive and manic symptoms in mixed depression
por: Tavares, Diego Freitas, et al.
Publicado: (2022)

Impacts of the COVID-19 Pandemic on Anxiety and Depressive Symptoms in Pregnant Women and Related Perinatal Outcomes
por: Han, Huan, et al.
Publicado: (2022)

Symptoms of Anxiety and Depression in Young Athletes Using the Hospital Anxiety and Depression Scale
por: Weber, Stephanie, et al.
Publicado: (2018)

Limited Depressive and Anxiety Symptoms Late in Pregnancy Are Not Related to Neonatal Outcomes
por: Varela, Pinelopi, et al.
Publicado: (2015)

Symptoms of depression, anxiety and stress in health students and impact on quality of life
por: de Freitas, Pedro Henrique Batista, et al.
Publicado: (2023)

Anxiety and depressive symptoms in patients with psoriasis
por: Sallemi, R., et al.
Publicado: (2021)

A Meta-Analysis of Observational Studies on the Association of Chronic Urticaria With Symptoms of Depression and Anxiety
por: Huang, Yuzhou, et al.
Publicado: (2020)

Examining Predictors of Depression and Anxiety Symptom Change in Cognitive Behavioral Immersion: Observational Study
por: Ezawa, Iony D, et al.
Publicado: (2023)

Dietary Patterns and Their Association with Anxiety Symptoms among Older Adults: The ATTICA Study
por: F. Masana, Maria, et al.
Publicado: (2019)

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
por: Ascher-Svanum, Haya, et al.
Publicado: (2014)

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study
por: Ascher-Svanum, Haya, et al.
Publicado: (2013)

Effect of Cardiac Rehabilitation on Quality of Life, Depression and Anxiety in Asian Patients
por: Choo, Carol C., et al.
Publicado: (2018)

Factors Associated with Depression and Anxiety Symptoms among Migrant Population in Spain during the COVID-19 Pandemic
por: Bayes-Marin, Ivet, et al.
Publicado: (2022)

No significant association between COVID-19 diagnosis and the incidence of depression and anxiety disorder? A retrospective cohort study conducted in Germany
por: Jacob, Louis, et al.
Publicado: (2022)

REOPENING UNDER COVID-19: THE IMPACT OF REOPENING SOCIETY ON OLDER ASIAN AMERICAN’S DEPRESSIVE SYMPTOMS
por: Lou, Yifan, et al.
Publicado: (2022)

Impact of Status-Based Rejection Sensitivity on Depression and Anxiety Symptoms in Gay Men
por: Slimowicz, Joseph, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_enhm1o095qpjvrbktqek6g3aeu